Chemokines in autoimmune disease

Current Opinion in Immunology

Volumn 13, Issue 6, 2001, Pages 670-675

  Godessart, Nuria ^a   Kunkel, Steven ^b  

^a Almirall Prodesfarma Research Center ^*  (Spain)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; AUTOIMMUNITY; CELL SURVIVAL; CHRONIC INFLAMMATION; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; TARGET ORGAN;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHEMOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MULTIPLE SCLEROSIS;

EID: 0035546057     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(01)00277-1     Document Type: Review

References (50)

1. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis
2. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains
3. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β1b
4. Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis
5. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
6. Macrophage inflammatory protein-1α, MIP-β, and RANTES mRNA semiquantificaiton and protein expression in active demyelinating multiple sclerosis lesions
7. Aberrant T cell migration toward RANTES and MIP-1 apha in patients with multiple sclerosis. Over-expression of chemokine receptor CCR5
8. Expression of the β-chemokine receptor CCR2, CCR3, CCR5 in multiple sclerosis central nervous system tissue
9. CCR5 δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
10. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1α by interferon-β
11. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
12. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR2)
13. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
14. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
15. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1
16. Update on synovitis
17. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium
18. The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)
19. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis
20. Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8
21. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes
22. CXC chemokines in angiogenesis
23. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint
24. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis
25. CXCR3 chemokine receptor distribution in normal and inflamed tissues: Expression on activated lymphocytes, endothelial cells, and dendritic cells
26. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential
27. + memory T cells in rheumatoid arthritis synovium
28. Persistent induction of the chemokine receptor CXCR4 by TGF-β1 on synovial T cells contributes to their accumulation within the rheumatoid synovium
29. + T cell accumulation in rheumatoid arthritis synovium
30. Lymphoid neogenesis: De novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines
31. Cell-cell interactions in synovitis. Interactions between T cells and B cells in rheumatoid arthritis
32. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal centers of ectopic lymphoid follicles within the synovium of chronic arthritis patients
33. Fibroblast like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism
34. Anti-TNFα therapy of rheumatoid arthritis: What have we learned?
35. Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: A new strategy in the treatment of chronic inflammatory diseases and HIV
36. Gene therapy for T cell-mediated autoimmunity: Teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines
37. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5
38. CC chemokine receptor 5 polymorphism in rheumatoid arthritis
39. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis
40. Design, synthesis, and discovery of a novel CCR1 antagonist
41. Chemokines: A new classification system and their role in immunity
42. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes
43. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes
44. Chemokines in autoimmune diseases
45. A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves' disease glands
46. Expression and regulation of regulated on activation, normal T cells expressed and secreted in thyroid tissue of patients with Graves' disease and thyroid autonomy and in thyroid-derived cell populations
47. 'Lymphoid' chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjogren's syndrome patients: Possible participation in lymphoid structure formation
48. Chemokine expression and leucocyte infiltration in Sjogren's syndrome
49. Circulating levels of β-chemokines in systemic lupus erythematosus
50. Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus